X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-14 | MTEM | Biotech Target N V | 10% | S - Sale+OE | $0.66 | -1,279,820 | 0 | -100% | -$845,833 | |||||
| D | 2024-04-02 | MTEM | Biotech Target N V | 10% | P - Purchase | $2.35 | +250,000 | 1,279,820 | +24% | +$587,500 | |||||
2023-10-02 | MGNX | Biotech Target N V | 10% | P - Purchase | $4.46 | +150,000 | 9,929,963 | +2% | +$669,585 | ||||||
2023-09-07 | MGNX | Biotech Target N V | 10% | P - Purchase | $5.26 | +200,000 | 9,779,963 | +2% | +$1,052,840 | ||||||
2023-07-17 | MTEM | Biotech Target N V | 10% | P - Purchase | $0.47 | +4,255,319 | 15,447,322 | +38% | +$2,000,000 | ||||||
2023-02-14 | MGNX | Biotech Target N V | 10% | P - Purchase | $5.07 | +500,000 | 9,579,963 | +6% | +$2,532,600 | ||||||
2023-01-19 | MGNX | Biotech Target N V | 10% | P - Purchase | $5.30 | +150,000 | 9,079,963 | +2% | +$794,925 | ||||||
| M | 2022-12-23 | MGNX | Biotech Target N V | 10% | P - Purchase | $5.75 | +400,000 | 8,929,963 | +5% | +$2,298,600 | |||||
2022-11-22 | MGNX | Biotech Target N V | 10% | P - Purchase | $5.96 | +300,000 | 8,529,963 | +4% | +$1,788,180 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |